Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00460122 · ClinicalTrials.gov registry record
Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 135
- Enrollment target
NCT00460122 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 135 participants.
The verdict
NCT00460122 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
Study Summary
This study will determine if transfusion of platelets containing HLA antibodies (certain antibodies to white blood cells) are more likely to cause transfusion reactions than transfusion of platelets that do not contain HLA antibodies. People 18 years of age or older who donate platelets at the NIH Clinical Center may be eligible for this study. An extra tube of blood (about one teaspoon) is obtained from participating donors at the time of their donation at the NIH Platelet Center. The blood plasma in the extra tube is tested for HLA antibodies and antibodies to certain white blood cells called granulocytes. The research sample is assigned a code number for identification and sent to the HLA Laboratory in the Department of Transfusion Medicine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2007-04-10 |
| Est. Completion | 2012-08-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00460122
The ClinicalTrials.gov registry entry for NCT00460122 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00460122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00460122 about?
NCT00460122 is a clinical study titled "Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients". This study will determine if transfusion of platelets containing HLA antibodies (certain antibodies to white blood cells) are more likely to cause transfusion reactions than transfusion of platelets that do not contain HLA antibodies. People 18 years of age or older who donate platelets at the NIH ...
What is the current status of trial NCT00460122?
This trial is currently completed. The enrollment target is 135 participants. The study started on 2007-04-10. Estimated completion is 2012-08-10.
Who is sponsoring clinical trial NCT00460122?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.